Partnership to develop next‑generation T‑cell engagers for solid tumours More: Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb Source: News
read more
First patient dosed as DOMISOL study grows beyond Australia More: Kainova expands DT 7012 trial into Europe Source: News
read moreSpecialty assets company Garda Therapeutics has acquired Assertio and its chemotherapy supportive care treatment Rolvedon for $125.1 million. In connection with the deal, Assertio has divested the rest of its assets to New Jersey generics and branded drugmaker Cosette Pharmaceuticals
read moreAbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount program. More: AbbVie challenges 'outdated' 340B drug discount program guidance in new lawsuit Source: fierce
read moreRobert F. Kennedy Jr. is starting a podcast. Unveiling the show on social media, the Department of Health and Human Services (HHS) secretary framed the podcast as a response to public health problems that he said have made “many of
read moreAvalyn Pharma is eyeing an IPO as the biotech seeks more funds to take its inhaled versions of approved drugs for lung conditions into phase 3 trials. More: Avalyn plans IPO to fund phase 3 trials of inhaled versions of
read more© 1994 - 2026 B.M. Pharmaceuticals